Provided By PR Newswire
Last update: Jan 9, 2023
New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications
Read more at prnewswire.com